PL2919755T3 - Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy - Google Patents

Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy

Info

Publication number
PL2919755T3
PL2919755T3 PL13799726T PL13799726T PL2919755T3 PL 2919755 T3 PL2919755 T3 PL 2919755T3 PL 13799726 T PL13799726 T PL 13799726T PL 13799726 T PL13799726 T PL 13799726T PL 2919755 T3 PL2919755 T3 PL 2919755T3
Authority
PL
Poland
Prior art keywords
bromobenzoyl
amino
composition containing
liquid composition
aqueous liquid
Prior art date
Application number
PL13799726T
Other languages
English (en)
Inventor
Angeliqueo E. Padilla
George A. Baklayan
Original Assignee
Bausch & Lomb Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb Incorporated filed Critical Bausch & Lomb Incorporated
Publication of PL2919755T3 publication Critical patent/PL2919755T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL13799726T 2012-11-19 2013-11-18 Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy PL2919755T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261727940P 2012-11-19 2012-11-19
EP13799726.8A EP2919755B1 (en) 2012-11-19 2013-11-18 Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
PCT/US2013/070510 WO2014078766A1 (en) 2012-11-19 2013-11-18 Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid

Publications (1)

Publication Number Publication Date
PL2919755T3 true PL2919755T3 (pl) 2018-07-31

Family

ID=49713470

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13799726T PL2919755T3 (pl) 2012-11-19 2013-11-18 Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy

Country Status (11)

Country Link
US (2) US20140142182A1 (pl)
EP (1) EP2919755B1 (pl)
JP (1) JP6128572B2 (pl)
KR (1) KR101748057B1 (pl)
CN (1) CN104812370B (pl)
AU (1) AU2013344497B2 (pl)
CA (1) CA2890182C (pl)
ES (1) ES2664053T3 (pl)
MX (1) MX358604B (pl)
PL (1) PL2919755T3 (pl)
WO (1) WO2014078766A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100341498C (zh) * 2003-01-21 2007-10-10 千寿制药株式会社 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂
WO2014204952A1 (en) * 2013-06-19 2014-12-24 Sentiss Research Center Stable bromfenac solution
RU2671639C1 (ru) * 2017-12-28 2018-11-06 Акционерное общество "Всероссийский научно-исследовательский институт по переработке нефти" (АО "ВНИИ НП") Альтернативное моторное топливо
CN111743858B (zh) * 2019-03-29 2023-06-27 天津药业研究院股份有限公司 一种溴芬酸钠的药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE400966B (sv) 1975-08-13 1978-04-17 Robins Co Inc A H Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror
US4758595A (en) * 1984-12-11 1988-07-19 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
CA1325382C (en) 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
ATE147619T1 (de) * 1992-05-13 1997-02-15 Sandoz Ag Opthalmische zusammensetzungen enthaltend ein cyclosporin
US5603929A (en) 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US6265444B1 (en) * 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
JP4106219B2 (ja) * 2001-02-01 2008-06-25 ロート製薬株式会社 点眼剤
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
CN100341498C (zh) * 2003-01-21 2007-10-10 千寿制药株式会社 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂
WO2005046700A1 (ja) * 2003-11-14 2005-05-26 Senju Pharmaceutical Co., Ltd. アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
TWI547522B (zh) * 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
WO2012108489A1 (ja) * 2011-02-10 2012-08-16 参天製薬株式会社 親水性薬物の薬物移行性を改善した水性組成物

Also Published As

Publication number Publication date
KR20150073225A (ko) 2015-06-30
MX358604B (es) 2018-08-28
WO2014078766A1 (en) 2014-05-22
KR101748057B1 (ko) 2017-06-15
MX2015006102A (es) 2015-08-06
ES2664053T3 (es) 2018-04-18
JP2016500069A (ja) 2016-01-07
AU2013344497A1 (en) 2015-05-21
JP6128572B2 (ja) 2017-05-17
US20200360326A1 (en) 2020-11-19
CA2890182C (en) 2020-10-06
EP2919755B1 (en) 2018-02-21
EP2919755A1 (en) 2015-09-23
US20140142182A1 (en) 2014-05-22
AU2013344497B2 (en) 2016-04-14
CA2890182A1 (en) 2014-05-22
CN104812370A (zh) 2015-07-29
CN104812370B (zh) 2018-05-08

Similar Documents

Publication Publication Date Title
HK1211569A1 (en) Amino acid derivatives
EP2884981A4 (en) BENZOIC ACID COMPOUNDS SUBSTITUTED WITH 4-HETEROARYL AS RORGAMMAT INHIBITORS AND USES THEREOF
IL237212A0 (en) Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators
SG11201405542UA (en) Artificial nucleic acid molecules
HK1208372A1 (en) Liquid formulation
IL235425B (en) History of lysine-glutamic acid di-peptide
EP2933867A4 (en) SOLID ELECTROLYTE CONTAINING IONIC LIQUID
AP4063A (en) Dimethyl-benzoic acid compounds
HK1206205A1 (en) Aqueous liquid composition containing collagen peptides
IL249826A0 (en) Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations
HK1210589A1 (en) Aqueous liquid medicine
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
HK1208198A1 (en) Branched aliphatic acid as liquid cation exchangers
PL2919755T3 (pl) Wodna ciekła kompozycja zawierająca kwas 2-amino-3-(4-bromobenzoilo)fenylooctowy
ZA201407638B (en) Structured aqueous liquid detergent
EP2814960A4 (en) USE OF IDED NANOSTRUCTURES IN NUCLEIC ACID TECHNOLOGY
SG11201405837YA (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
HK1214587A1 (zh) 肉桂酰胺衍生物
EP2910558A4 (en) IONIC LIQUID
IL238790A0 (en) Capsule composition of 5-amino salicylic acid
HK1220393A1 (zh) 含有經穩定化的 -氨基- -溴苯甲醯基 苯乙酸的水性組合物
IL235539B (en) Liquid sprayer
TH148762B (th) อนุพันธ์ของพิร์โรลิดีน-3-อิลแอซีติก แอซิด
AP00764S1 (en) Liquid applicator